A new study suggests that SARS-CoV-2, the virus that causes COVID-19, is most likely to target specific cells present in the nasal passages, lungs, and

Read more

A new study in cell cultures suggests that ivermectin, an existing antiparasitic drug, is able to eliminate SARS-CoV-2 within 48 hours. However, whether this approach

Read more

Experimental Ebola drug remdesivir could stop SARS-CoV-2 from replicating by acting on a key enzyme, according to a new study from the University of Alberta.

Read more